Management of COPD exacerbations : Recommendation from European Respiratory Society / American Thoracic Society guideline

Abstract:disease (COPD) is often punctuated by “exacerbations”, defined clinically as episodes of increasing respiratory symptoms, particularly dyspnoea, cough and sputum production, and increased sputum purulence. COPD exacerbations have a negative impact on the quality of life of patients with COPD, accelerate disease progression, and can result in hospital admissions and death. Evidence-based clinical practice guidelines have been developed by other organisations that recommend inhaled bronchodilator therapy for patients having a COPD exacerbation, as well as supplemental oxygen for hypoxaemic patients. They also make recommendations related to systemic steroids, antibiotic therapy, noninvasive mechanical ventilation (NIV) and home-based management. The purpose of our guidelines is to update the latter recommendations and to address specific questions regarding the treatment of COPD exacerbations that are not answered by existing guidelines. For the following six questions, we employed a systematic review of the literature followed by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop treatment recommendations.

Medicine